Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California (PACB) recorded quarterly Other Non-Current Assets of $1.6 million in Q1 2026, up 3.79% quarter-over-quarter from $1.5 million in Q4 2025, and down 28.44% on a YoY basis from $2.2 million in Q1 2025.

Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Pacific Biosciences Of California's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 28.44% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 28.44% YoY), while the FY2025 annual figure was $1.5 million, down 83.54% from the prior year.
  • Other Non-Current Assets was $1.6 million for Q1 2026 at Pacific Biosciences Of California, up from $1.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.3 million in Q4 2024 to a low of $1.5 million in Q2 2025.
  • Historically, Other Non-Current Assets has averaged $3.0 million across 5 years, with a median of $2.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 241.84% in 2024, then tumbled 83.54% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.2 million in 2022, then slipped by 15.52% to $2.7 million in 2023, then jumped by 241.84% to $9.3 million in 2024, then sank by 83.54% to $1.5 million in 2025, then increased by 3.79% to $1.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 3.17 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 4.04 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 738.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 828.89 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 285.90 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.25 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 211.40 Mn
10 Pacific Biosciences Of California 426.62 Mn 150.66 Mn 12.84 Mn 1.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.59 Mn
Dec 31, 2025 1.53 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.53 Mn
Mar 31, 2025 2.22 Mn
Dec 31, 2024 9.31 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 2.26 Mn
Mar 31, 2024 2.72 Mn
Dec 31, 2023 2.72 Mn
Sep 30, 2023 2.72 Mn
Jun 30, 2023 2.72 Mn
Mar 31, 2023 3.22 Mn
Dec 31, 2022 3.22 Mn
Sep 30, 2022 3.22 Mn
Jun 30, 2022 3.22 Mn
Mar 31, 2022 5.48 Mn
Dec 31, 2021 5.09 Mn
Jun 30, 2021 3.30 Mn
Mar 31, 2021 4.34 Mn